CAN-PDP: Cannabidiol (CBD) for people with Parkinson's who experience hallucinations or delusions
Research teams across the UK aim to investigate whether CBD is an effective treatment for hallucinations and delusions.
120 people with Parkinson’s who:
• are over 40 years old
• have experienced any symptoms of psychosis for at least one month. This could include seeing, hearing, or feeling things that aren’t there and mistaking objects for other things (hallucinations). For example, a pile of clothes might look like a dog. Symptoms could also include unusual thoughts, beliefs, or worries that aren't based on reality (delusions)
• have been taking any Parkinson’s medications for at least one month
• are not taking clozapine
• and have someone who can attend study visits with them
If you are eligible to take part, you will either receive the study treatment (CBD) or a placebo treatment (such as a sugar pill) for 12 weeks.
You will be asked to attend up to 6 visits. Some of these can take place over the telephone or online, and others will need to take place at your local research centre or at your home. Each visit will last between 1 and 3 hours. During the visits, you may be asked to give blood samples, complete surveys, or physical examinations.
You can also optionally take part in 2 MRI scans.
Find more information in the following participant information sheets:
• Read the participant information sheet for people with Parkinson’s.
• Read the participant information sheet for accompanying loved ones or carers.
Interested in taking part?
Scroll down to find your nearest study site location, click on the arrow and contact the relevant research team.
The deadline for taking part in this research is 1 March 2025.
If you have any questions, please contact the Research Team by email at [email protected].
More information
You can stay up to date with news from the study on Twitter @CANPDP_trial or Facebook at www.facebook.com/CAN.PDP
This is a phase 2 research study. Previous studies suggest that CBD may be useful in treating symptoms of psychosis, they also suggest that it is safe to use in older adults. Find out more about the different phases of medical research.
Parkinson's UK
King's College Hospital, Denmark Hill
London
SE5 9RS
United Kingdom
Sara Pisani
Email: [email protected]
Phone: 07936545178
There is also a research site at South London and Maudsley NHS Foundation Trust, Michael Rutter Centre, London SE5 8AZ. Please contact Sara Pisani using the above contact details if you'd like to take part at the Michael Rutter Centre.
St George's University Hospitals NHS FT, Blackshaw Road,
London
SW17 0QT
United Kingdom
Claire Gilmartin
Email: [email protected]
Royal United Hospital, Combe Park
Bath, Avon
BA1 3NG
United Kingdom
Royal Hallamshire Hospital, Broomhill, Glossop Rd
Sheffield
S10 2JF
United Kingdom
St Peter's Hospital, Guildford St, Lyne,
Chertsey
KT16 0PZ
United Kingdom
Derbyshire Healthcare NHS Foundation Trust,
Centre for Research and Development, Kingsway Hospital, Kingsway
Derby
DE22 3LZ
United Kingdom
Royal Gwent Hospital, Cardiff Road,
Newport
NP20 2UB
United Kingdom
Clinical Trial Coordinator, Jemma Tufney
Email: [email protected]
Prince Philip Hospital, Bryngwyn Mawr,
Llanelli
SA14 8QF
United Kingdom
Wrexham Maelor Hospital, Croesnewydd Road,
Wrexham
LL13 7TD
United Kingdom
Clinical Research Specialist Officer, Claire Watkins
Email: [email protected]
Cornwall Partnership NHS Foundation Trust, Carew House, Beacon Technology Park, Dunmere Rd,
Bodmin
PL31 2QN
United Kingdom
Tayside Medical Science Centre, Ninewells Hospital & Medical School
Dundee
DD1 9SY
United Kingdom
Kate Ferguson
Email: [email protected]
Withybush General Hospital
Fishguard Road
Haverfordwest
Pembrokeshire
SA61 2PZ
United Kingdom